Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 29 Breast Neoplasms 28 Brain Neoplasms 21 Neoplasms 16 Glioma 10 Pancreatic Neoplasms 9 Head and Neck Neoplasms 8 Lymphoma 7 Uterine Cervical Neoplasms 6 Urinary Bladder Neoplasms 6 Rectal Neoplasms 6 Glioblastoma 6 Colonic Neoplasms 6 Carcinoma, Hepatocellular 6 Lymphoma, Non-Hodgkin 5 Lung Neoplasms 5 Astrocytoma 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Liver Neoplasms 4 Disease 4 Central Nervous System Neoplasms 4 Stomach Neoplasms 3 Spinal Cord Neoplasms 3 Sarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Esophageal Neoplasms 3 Carcinoma in Situ 3 Retinoblastoma 2 Pathologic Complete Response 2

Interventions

temsirolimus 1 binimetinib 1 Valproic Acid 1 Trabectedin 1 Specimen Handling 1 Sirolimus 1 Magnetic Resonance Imaging 1 Laser Therapy 1 Indocyanine Green 1 Immunoglobulin G 1 High-Energy Shock Waves 1 Enoxaparin 1 Disulfides 1 Cetuximab 1 Biopsy 1 Bevacizumab 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Soft Tissue Neoplasms × Magnetic Resonance Imaging × Clear all

NCT04394052 2020-07-21

TUMOSTEO II

Central Hospital, Nancy, France

Bone Neoplasms, Neoplasms, Soft Tissue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡